The Food and Drug Administration’s approval of lecanemab, a new Alzheimer’s medication shown in clinical trials to reduce the disease slowly over time.
Colossal Biosciences, the business seeking to make extinction optional, has resurrected a prehistoric predator best known for its role in Game of Thrones. Approximately 20 [Read More…]
Amino acids are chemical compounds that act as the basic building blocks for proteins. They perform vital functions in a variety of biological processes and [Read More…]
Eliminating amyloid from the brain may prevent symptoms in those who are destined to acquire early-onset Alzheimer’s disease, according to a clinical experiment. This suggests the need for additional research.
The researchers created a highly effective conversion technique using mouse cells that can generate over ten neurons from a single skin cell.
Using a novel animal model of Alzheimer’s disease, the study raises the possibility of a breakthrough in therapeutic approaches.
A recent partnership between Georgia Tech and Northwestern University has created a new high-performance organic electrochemical neuron that responds in the same frequency range as human neurons, opening up new possibilities for the area.
The immune cells of the central nervous system are known as microglia. Because they remove poisons from the brain and central nervous system, microglia are essential for preserving neuronal function.
Although embryonic cells exhibit amazing adaptability at this dynamic stage of early development, it is still unknown what molecular mechanisms and variables govern this plasticity.
An ion channel, a protein that creates a passageway for electrical charges to flow through the protective outer membrane, is present in these vesicles, according to a recent study conducted by a group of medical researchers at The Ohio State University
